| Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action K Nagaraj, L Lapkina-Gendler, R Sarfstein, D Gurwitz, M Pasmanik-Chor, ... Proceedings of the National Academy of Sciences 115 (5), 1045-1050, 2018 | 62 | 2018 |
| Genome-wide profiling of laron syndrome patients identifies novel cancer protection pathways H Werner, L Lapkina-Gendler, L Achlaug, K Nagaraj, L Somri, ... Cells 8 (6), 596, 2019 | 45 | 2019 |
| Effects of GH/IGF on the aging mitochondria SB Poudel, M Dixit, M Neginskaya, K Nagaraj, E Pavlov, H Werner, ... Cells 9 (6), 1384, 2020 | 38 | 2020 |
| Laron syndrome research paves the way for new insights in oncological investigation H Werner, R Sarfstein, K Nagaraj, Z Laron Cells 9 (11), 2446, 2020 | 28 | 2020 |
| The olfactory receptor gene product, OR5H2, modulates endometrial cancer cells proliferation via interaction with the IGF1 signaling pathway R Shibel, R Sarfstein, K Nagaraj, L Lapkina-Gendler, Z Laron, M Dixit, ... Cells 10 (6), 1483, 2021 | 17 | 2021 |
| Differential effects of insulin and IGF1 receptors on ERK and AKT subcellular distribution in breast cancer cells R Sarfstein, K Nagaraj, D LeRoith, H Werner Cells 8 (12), 1499, 2019 | 16 | 2019 |
| Identification of nephronectin as a new target for IGF1 action R Sarfstein, L Lapkina-Gendler, K Nagaraj, Z Laron, H Werner European Journal of Cancer 141, 115-127, 2020 | 15 | 2020 |
| Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer L Achlaug, R Sarfstein, K Nagaraj, L Lapkina-Gendler, I Bruchim, M Dixit, ... Oncotarget 10 (43), 4437, 2019 | 11 | 2019 |
| Long-term IGF1 stimulation leads to cellular senescence via functional interaction with the thioredoxin-interacting protein, TXNIP K Nagaraj, R Sarfstein, Z Laron, H Werner Cells 11 (20), 3260, 2022 | 8 | 2022 |
| Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence L Somri, R Sarfstein, L Lapkina-Gendler, K Nagaraj, Z Laron, LA Bach, ... Growth Hormone & IGF Research 39, 6-12, 2018 | 8 | 2018 |
| Genome-wide profiling of congenital IGF1 deficient patients: Translational implications in cancer prevention and metabolism H Werner, L Lapkina-Gendler, K Nagaraj, R Sarfstein, Z Laron Transl. Med. Rep 1, 6657, 2017 | 6 | 2017 |
| Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action R Sarfstein, K Nagaraj, S Parikh, C Levy, Z Laron, D Benayahu, H Werner Cells 11 (10), 1627, 2022 | 4 | 2022 |
| MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression D Yaron-Saminsky, K Nagaraj, R Sarfstein, Z Laron, M Pasmanik-Chor, ... International Journal of Molecular Sciences 22 (21), 11861, 2021 | 3 | 2021 |
| Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action. Cells 2022, 11, 1627 R Sarfstein, K Nagaraj, S Parikh, C Levy, Z Laron, D Benayahu, H Werner s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| Erratum to ‘Identification of nephronectin as a new target for IGF1 action’[Eur J Canc 141 (2020) Pages 115–127] R Sarfstein, L Lapkina-Gendler, K Nagaraj, Z Laron, H Werner European Journal of Cancer 148, 453-454, 2021 | | 2021 |
| Genome-wide profiling of congenital insulin-like growth factor-1 deficient patients: translational implications in cancer prevention and metabolism H Werner, LL Gendler, K Nagaraj, R Sarfstein, Z Laron Translational Medicine Reports 1 (2), 2017 | | 2017 |
